StayinFront Announces Multi-Year Agreement with Napo Pharmaceuticals, Inc.
FAIRFIELD, NJ (July 12, 2021) – StayinFront, a leading global provider of mobile, cloud-based customer relationship management (CRM) solutions for life sciences and consumer goods organizations, announced today a multi-year agreement with Napo Pharmaceuticals, Inc. (“Napo”), a pharmaceutical company committed to discovering, developing, and commercializing plant-based prescription medicines for urgent global health needs, to deploy its Touch Platform suite of products. Napo is a wholly-owned subsidiary of Jaguar Health, Inc.
StayinFront will provide StayinFront TouchRx® to Napo’s field representatives to access critical CRM information. The solution will allow Napo representatives to leverage advanced targeting tools to create effective schedules for communicating with key healthcare providers. Integrated Closed Loop Marketing (CLM) will maximize customer insight through targeted messaging and engaging multimedia presentations that will drive higher quality interactions and stronger relationships. StayinFront Briefcase® will enable Napo field representatives to seamlessly manage, store and distribute pre-approved selling materials.
“We evaluated a number of solutions and selected StayinFront’s product suite for its features, roadmap and support level. StayinFront offers configurable product solutions that will allow Napo to leverage customer and market information and improve the effectiveness of our field sales activities,” stated Roneil Narciso, Jaguar Health’s Commercial Operations Director.
“The StayinFront TouchRx platform is designed to deliver relevant, cost effective and easy-to-maintain mobile cloud products and services. Napo has set an aggressive timeline to deploy and our experienced, dedicated life sciences team will ensure project success. We are confident we will help Napo Know More, Do More and Sell More in a compliant manner,” commented Ken Arbadji, Vice President Sales, North America at StayinFront.
About Jaguar Health, Inc., Napo Pharmaceuticals, Inc. & Napo EU S.p.A.
Jaguar Health, Inc. is a commercial stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Our wholly owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary plant-based human gastrointestinal pharmaceuticals from plants harvested responsibly from rainforest areas. Our Mytesi® (crofelemer) product is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy and the only oral plant-based prescription medicine approved under FDA Botanical Guidance. Napo Pharmaceuticals’ wholly owned Italian subsidiary, Napo EU S.p.A., focuses on expanding crofelemer access in Europe.
For more information about Jaguar, please visit https://jaguar.health. For more information about Napo Pharmaceuticals, visit www.napopharma.com. For more information about Napo EU, visit www.napoeu.com.
StayinFront is a leading global provider of mobile, cloud-based field force effectiveness and customer relationship management solutions for Life Sciences organizations and Consumer Goods. Companies of all sizes, in over 50 countries use StayinFront software to streamline sales operations and reduce the complexity, time, and expense associated with field efforts. StayinFront products are seamlessly integrated to provide companies with timely, accurate field data and actionable insights, enabling field reps and management to Know More, Do More, and Sell More. Headquartered in Fairfield, New Jersey, StayinFront has offices in Chicago, Canada, the United Kingdom, Turkey, Ireland, Poland, India, Australia, Singapore, and New Zealand. Through its StayinFront Retail Data Insight (RDI) and StayinFront Digital subsidiaries, StayinFront delivers stand-alone and tightly integrated actionable insights and guided selling by analyzing retail images and data to brand managers and sales forces around the globe. For more details about StayinFront products and solutions, visit http://dev.stayinfront.com/.
Vice President of Sales, North America
+1 (973) 461-4800 x3247
+44 (0) 1494 429 565 x7216